BrainStorm Announces Presentations at June 2022 Scientific Conferences
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announces...
Source: prnewswire.com